PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Chart, page-4226

  1. 7,587 Posts.
    lightbulb Created with Sketch. 6863
    Unless a partnership or rumour of announced, this could be sold down further on EOFY selling late into June (to state the obvious) - and I will be buying more if so.

    No one ever remembers the long-term holders who held for years and finally sold out, when these things rise from the ashes. Just celebrate the save by the CEO forgetting his long-term under performance.

    At these prices PR cannot strongly negotiate a strong deal even if he does get one. Any joint venture partner more likely to walk away and consider a takeover. An easy $200 million takeover would get you to the negotiating table, so if PR demands silly things like $50 million upfront and $100 million in milestone payments (that he might have when it was trading $2) for example, any sensible suitor would surely think of taking it all for not much more.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.